Lexington, MA, United States of America

Bohong Zhang

This inventor holds 8 USPTO granted patents and 6 published patent applications and 4 EPO patents. Top assignees: Shire Human Genetic Therapies, Inc., Takeda Pharmaceutical Company Limited, Criteo S.a.. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bohong Zhang. Retrieved from https://idiyas.com/inventor/bohong-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 75.0

 

Average Co-Inventor Count = 6.6

ph-index = 3

Forward Citations = 18(Granted Patents)


Location History:

  • Newton, MA (US) (2017 - 2021)
  • Lexington, MA (US) (2017 - 2023)

Company Filing History:


Years Active: 2017-2026

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovations of Inventor Bohong Zhang

Introduction

Bohong Zhang, a prominent inventor based in Lexington, MA, holds an impressive portfolio of 7 patents. His contributions to the field of biochemistry and enzyme therapy demonstrate a commitment to advancing scientific knowledge and practical applications in healthcare.

Latest Patents

Among his latest innovations, Zhang has developed a method for the affinity purification of glycosidase-cleaving enzymes. This invention relates to an affinity resin functionalized with small molecule inhibitors of enzymes such as α-galactosidase A, glucocerebrosidase, β-galactosidase, and acid alpha-glucosidase. The technique uses a small molecule inhibitor-functionalized affinity resin to efficiently purify glycoside-cleaving enzymes produced in a cell line.

Another significant patent involves a therapeutic fusion protein that comprises an alpha-N-acetylglucosaminidase and a lysosomal targeting moiety. This invention aims to treat Sanfilippo syndrome type B through methods that include the intrathecal administration of a Naglu protein. The Naglu protein can be a recombinant, gene-activated, or natural protein, often designed as a fusion protein with a lysosomal targeting moiety, such as an IGF-II moiety.

Career Highlights

Bohong Zhang has significantly impacted the field while working with reputable organizations including Shire Human Genetic Therapies, Inc. and Criteo S.A. His work has paved the way for advancements in genetic therapies and innovative treatments for rare diseases.

Collaborations

Throughout his career, Zhang has worked alongside notable colleagues such as Michael F. Concino and Muthuraman Meiyappan. These collaborations have fostered an environment of creativity and innovation, contributing to his successful patent portfolio.

Conclusion

Bohong Zhang exemplifies the spirit of innovation in the therapeutic and biochemistry fields. His patents showcase groundbreaking approaches to enzyme purification and treatment methodologies, making significant strides towards improving healthcare outcomes. As he continues his work, the implications of his inventions are likely to have lasting impacts on both scientific research and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…